‹ All Posts
RAJIV GUPTA (SEBI RA)

4th Jul 2025 · SEBI-Registered Analyst

Llaunch genomics lab - Suraksha Diagnostic Ltd

BSE: 544293 NSE:

SURAKSHA
“Suraksha Diagnostic Limited unveils Eastern India’s largest & first state-of-the-art genomics lab with a grand inauguration event.” This State-of-the-Art Genomics Lab is equipped with Cytogenetics, Microarray Technology, Sanger Sequencing, Multiple Next-Generation Sequencers (NGS). Together, these technologies enable the full spectrum of advanced genetic testing, offering predictive, preventive, and personalized care. Suraksha Diagnostic’s Genomics Lab enables the detection of chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome, as well as sex chromosome aneuploidies and microdeletions. These insights help expecting parents make informed decisions, supported by expert genetic counseling.

#StockInNews#WatchOutFor
sd04072025.pdf
771 likes·65 comments